Chief Medical Officer
Pamela has more than 20 years of biotech and pharma experience, leading and driving clinical, medical and regulatory activities from trial design and execution through product approval, launch and commercialization. She joined Freeline in November 2021, having previously served as Chief Medical Officer at Auregen BioTherapeutics SA and Aegerion Pharmaceuticals and worked in hemophilia and neurology at Biogen and on lysosomal storage diseases at Genzyme. Pamela received her Bachelor of Science and medical degrees from Georgetown University and trained in neurology at Stanford University Hospital.
Connect with Pamela: